...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rumors starting again
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree with you on the rumour front as Zen/RVX management has been way long on yapping and with almost zero accomplishment on the business/shareholder return front. Fuzz why would you expect movement in Hepa's sp given they have no ownership in Zenith?

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply